Navigation Links
Elekta and Mary Bird Perkins Cancer Center Sign Strategic Multi-Center Radiation Therapy Systems Agreement
Date:6/5/2008

ATLANTA, June 5 /PRNewswire/ -- Elekta, a world class leader in advanced radiation therapy and radiosurgery, has been selected to supply multiple Elekta Synergy(R) digital linear accelerator systems to Mary Bird Perkins Cancer Center over the next few years.

The new Elekta Synergy systems will provide expanded capacity for advanced Image Guided Radiation Therapy (IGRT), which Mary Bird Perkins (MBP) began providing to patients four years ago. The new systems will provide for MBP's current locations as well as the organization's long-term regional growth into new markets. MBP has locations in Baton Rouge, Hammond and Covington and is building a fourth location in Gonzales, LA.

Each of the estimated nine new treatment systems will include 3D X-ray Volume Imaging (XVI) and some will include ElektaVMAT Volumetric intensity Modulated Arc Therapy, enhancing MBP's Intensity Modulated Radiation Therapy (IMRT) and IGRT arsenal.

"We feel that Elekta is 'first class in its field' and provides dynamic, practical and reliable treatment options," said Todd D. Stevens, President and CEO, MBP. Every cancer case is unique and personal, and Mary Bird Perkins makes sure that it has the best radiation therapy options available to our treatment team so every cancer patient has individualized, optimal treatment."

The Center will be treating all types of cancer with the Elekta Synergy systems, from simple to the most complex cases. Elekta Synergy is a fully-digital linear accelerator with an integrated 3D imaging system that simultaneously acquires and reconstructs image data on the target and surrounding critical structures as a whole volume in a single gantry sweep. Because imaging occurs at the time of treatment, uncertainties due to organ motion or deformation and slight differences in patient set-up can be eliminated.

In its search for the best solution for patient care, Mary Bird Perkins diligently analyzed all proposals and mobilized a team
'/>"/>

SOURCE Elekta Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Xoft Signs Sales Development Agreement With Elekta
2. Mass Financial Corp. Launches Lawsuit Against Elekta AB, Seeks Substantial Damages
3. Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
4. Emageon Names Chris E. Perkins as Chief Operating Officer
5. Kylies breast cancer triggered a surge of over 30 percent in breast imaging of low-risk women
6. Synthetic molecules hold promise for new family of anti-cancer drugs
7. Insights into cancer earn Premiers Award Commendation
8. Take a Swing Against Breast Cancer!
9. Family history of colorectal cancer linked with reduced risk of cancer recurrence
10. Androgen Production Continues in Prostate Cancer Tumors
11. Family History Might Improve Odds Against Colon Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins Ltd. tod...1N1 virus genomic data. It shows that the lethali...s.d. 4.5) during the virus,s current outbreak in t...his week of 2.0 (s.d. 0.1). The H1N1 infectivity c... Boston (PRWEB) November 27, 2009 -- Bio...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewsw... professional cycling team dedicated to ethical sp...ng champions, announced today that it will become ...itions Optical as a new sponsor of the team. Trans... of adaptive eyewear, offering the most advanced p...
(Date:11/27/2009)... rates to bring unprecedented medical, economic bu...7 (HealthDay News) -- The number of people with di...over the next 25 years, a new study predicts. ,...million people with the disease, up from 23.7 mill...ating people with diabetes will triple, the study ...
(Date:11/27/2009)... Specialist manufacturers who us...s are saving millions of dollars by bringing in te...ss. Increasing numbers of pro-active medical manuf...at the concept stage of their projects, ensuring t...esign processes or potentially outdated technology...
(Date:11/26/2009)...e next 25 years, the number of Americans living wi....7 million in 2009 to 44.1 million in 2034. Over t...riple, rising from $113 billion to $336 billion, e... researchers based at the University of Chicago re... The number of those with diabetes covered by Medi...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
..., SAN DIEGO, Jan. 6 NuVasive, Inc. (Nasdaq: NU...ng products for minimally disruptive surgical trea...kianov, Chairman and Chief Executive Officer, is s...2009, at 11:00 a.m. PT. , , A live Web cast of th...
..., SAN DIEGO, Jan. 6 Orexigen(R) Therapeutics,...ny focused on the treatment of,obesity, today anno...h Annual,J.P. Morgan Healthcare Conference. The de... California, Webcast link: , http://metameetin...
..., Frontier Service Design Creates Tangible Value b... Jan. 6 Frontier Service Design, LLC, a firm that...s that create new and recurring revenue streams fo... around business opportunities that yield new sour...
..., Completed Phase 2 Bladder Augment Trial and Plan...kthrough in Kidney Regeneration Program: Preclini...ON, Pa., Jan. 6 Tengion Inc., a clinical-stage or...ef executive officer, is scheduled to present at t...
..., MILAN, Italy, Jan. 6 A pancreatic cancer pa...reated using a new, faster form of,radiotherapy th... while,extending more advanced care to more patien.... , "We see three major benefits with RapidArc...
..., Rock & Roll Hall of Fame inductees Jackson B...ing attention to the nation,s biggest problem: the...nt Emissary, a DC-based event planning company, an...ll Blue Diamond Ball will be held January 20, 2009...
Other Medicine News:Health News:NuVasive to Present at 27th Annual J.P. Morgan Healthcare Conference 2Health News:First Service Design Firm Launches in United States 2Health News:Tengion to Present at 27th Annual JP Morgan Healthcare Conference 2Health News:First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center 2Health News:First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center 3Health News:Health for All Blue Diamond Ball Scheduled to Celebrate Obama's Inauguration 2
(Date:11/25/2009)...a, Nov. 25 /PRNewswire-Asia-FirstCall/ -- China Sk...he Company") (Nasdaq: CSKI ), a,leading fully int...ucing,over-the-counter drugs in the People,s Repub...pany recently passed the Chinese National Institut... Products ("ICPBP") examination,for two of its new...
(Date:11/25/2009)... Nov. 25 According to Millennium R...al technology market intelligence, the nearly $3 b...continue to see rapid growth over the next five ye...S Markets for Trauma Devices 2010 report finds ...he next five years, with competitors introducing s...
(Date:11/25/2009)...herlands and JOHANNESBURG, November 25 /PRNewswire... Pyxis Discovery announced today,that they have si...oth,companies, services. , Pyxis,s world ...xpertise,will be coupled with iThemba,s service di...y support to projects identified through Pyxis,in...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Home For the Holidays 3A MyShrink com Announces the Second in its Successful Six Part Webinar Series 3A 26quot 3BAbandonment 3A The Hidden Fear 26quo 62006 1Home For the Holidays 3A MyShrink com Announces the Second in its Successful Six Part Webinar Series 3A 26quot 3BAbandonment 3A The Hidden Fear 26quo 62006 2Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 62004 1Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 62004 2Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 62004 3Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 62004 4NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Deal 62002 1NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Deal 62002 2
..., April 17 Schering-Plough,Corporation (NYSE: SG...nt of,chronic hepatitis C virus (HCV) infection, a...dy as well as from several other clinical studies,...ETOL(R) (ribavirin, USP),combination therapy will ...tudy of the Liver (EASL) 43rd annual meeting in Mi...
... April 16 Kosan Biosciences,Incorporated (Nasdaq:...tary,nuclear export inhibitors (NEI) showing poten...ility in leukemia xenograft models, and further,el...orrelating inhibition,of the target CRM1 with indu...pared to normal cells. Data on Kosan,s NEIs were p...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 9Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR 2Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR 3Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR 4
New Image Lock 'n Roll Drainable Pouch, Transparent with Filter
New Image Drainable Pouch,
New Image Drainable Pouch with Filter,
New Image Drainable Mini-Pouch, Beige with Lock 'n Roll
Medicine Products: